Skip to main content
HUALAN GROUP CO.,LTD. logo

HUALAN GROUP CO.,LTD. — Investor Relations & Filings

Ticker · 301027 ISIN · CNE100004MH7 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 662 across all filing types
Latest filing 2024-04-23 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 301027

About HUALAN GROUP CO.,LTD.

https://www.gxhl.com

Hualan Group Co., Ltd. specializes in the research, development, and manufacturing of primary pharmaceutical packaging materials. The company's core product portfolio includes high-quality butyl rubber stoppers, aluminum-plastic combination caps, and plastic components designed for injectable medications and infusion sets. These products are engineered to ensure drug stability and compatibility, meeting international quality standards such as GMP. Serving a global clientele of pharmaceutical manufacturers, the group focuses on advanced material science and precision manufacturing to provide secure sealing solutions for vaccines, antibiotics, and blood products. By integrating R&D with large-scale production capabilities, the company maintains a significant role in the pharmaceutical supply chain, emphasizing safety and reliability in drug delivery systems.

Recent filings

Filing Released Lang Actions
太平洋证券股份有限公司关于华蓝集团股份公司2024年日常关联交易预计的核查意见
Regulatory Filings Classification · 95% confidence The document is a detailed verification opinion from a sponsoring securities company regarding the expected daily related-party transactions of a listed company for the year 2024. It includes extensive data on related-party transactions, their pricing policies, contract amounts, actual amounts, and the relationship and financial status of related parties. It also describes the board and independent directors' review and approval process, as well as the sponsor's verification opinion. The document is not a full annual or interim financial report but rather a specialized report on related-party transactions and their compliance with regulations and governance. This type of document fits best under the category of Regulatory Filings (RNS) because it is a regulatory disclosure related to compliance and governance of related-party transactions, not a full financial report or a simple announcement. The document length (8731 characters) and content confirm it is a substantive regulatory filing rather than a brief announcement or certification.
2024-04-23 Chinese
关于2023年度募集资金存放与使用情况的专项报告
Capital/Financing Update Classification · 95% confidence The document is a detailed report on the management and usage of funds raised by the company through a public stock issuance. It references regulatory guidelines from the China Securities Regulatory Commission and Shenzhen Stock Exchange, and provides comprehensive data on the amount raised, usage, storage, and management of the funds. The document includes tables showing the allocation and usage of the raised capital, mentions audit verification reports, and discusses compliance with regulatory requirements. The content focuses specifically on the use and management of raised funds rather than general financial performance or earnings. This matches the description of a Capital/Financing Update (CAP), which covers updates on company fundraising and capital structure changes. The document length (8095 characters) and detailed financial data support classification as a substantive report rather than a brief announcement or certification. Therefore, the appropriate classification is CAP with high confidence.
2024-04-23 Chinese
关于聘任公司高级管理人员的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the appointment of a senior management personnel (investment director) at 华蓝集团股份公司. It includes details about the appointment process, qualifications, and background of the appointee. There is no financial data, no mention of financial results, no regulatory filings about financial performance, and no indication of a report being attached or published. The content clearly fits the category of Board/Management Information, which covers announcements of changes in senior management.
2024-04-23 Chinese
关于作废2022年限制性股票激励计划部分已获授但尚未归属的第二类限制性股票的公告
Regulatory Filings Classification · 95% confidence The document is an official announcement from a company regarding the cancellation of certain restricted stock awards under a 2022 stock incentive plan. It details board and supervisory committee meetings, legal opinions, and the procedural background for the cancellation of unvested restricted shares due to retirement and unmet performance targets. The document does not contain financial statements or detailed financial performance data but rather focuses on corporate governance actions related to stock incentives. It is a formal announcement about changes in stock incentive awards, not a full financial report or earnings release. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous official corporate announcements that do not fit other specific categories.
2024-04-23 Chinese
会计师事务所对公司控股股东及其他关联方资金占用情况的专项说明
Audit Report / Information Classification · 95% confidence The document is a detailed audit-related report concerning the use of funds by controlling shareholders and related parties of 华蓝集团股份公司 for the fiscal year 2023. It includes references to audited financial statements, audit opinions, and compliance with regulatory requirements from Chinese regulatory bodies such as the China Securities Regulatory Commission and others. The document contains tables summarizing non-operating fund occupation and related party transactions, and it is signed by certified public accountants with audit report codes and certification details. The content is focused on audit verification and financial compliance rather than being a full annual report or a simple announcement. It is not a brief announcement or a certification letter but a standalone audit report or special audit information related to the company's financials and regulatory compliance. Therefore, the most appropriate classification is Audit Report / Information (AR). FY 2023
2024-04-23 Chinese
关于2024年度日常关联交易预计的公告
Regulatory Filings Classification · 95% confidence The document is a detailed announcement regarding the company's expected related party transactions for the fiscal year 2024 and actual related party transactions for 2023. It includes information about the board meeting resolutions, independent directors' opinions, and the sponsor's verification opinion. The document focuses on the disclosure of related party transactions, their pricing policies, and the impact on the company and shareholders. It is not a financial report like an annual or interim report, nor is it a call transcript or earnings release. It is also not a report publication announcement or a certification. The content fits the category of a Regulatory Filing (RNS) because it is a regulatory disclosure about related party transactions required by stock exchange rules and laws, but it does not fit into more specific categories like MANG (management changes) or CAP (capital updates). Therefore, the best classification is Regulatory Filings (RNS). The document length (8645 characters) and detailed content support this classification with high confidence.
2024-04-23 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.